Literature DB >> 10652335

Stability-activity relationships of a family of G-tetrad forming oligonucleotides as potent HIV inhibitors. A basis for anti-HIV drug design.

N Jing1, E De Clercq, R F Rando, L Pallansch, C Lackman-Smith, S Lee, M E Hogan.   

Abstract

Recently, we have demonstrated that T30695, a G-tetrad-forming oligonucleotide, is a potent inhibitor of human immunodeficiency virus, type I (HIV-1) integrase and the K(+)-induced loop folding of T30695 plays a key role in the inhibition of HIV-1 integrase (Jing, N., and Hogan, M. E. (1998) J. Biol. Chem. 273, 34992-34999). Here we have modified T30695 by introducing a hydrophobic bulky group, propynyl dU, or a positively charged group, 5-amino dU, into the bases of T residues of the loops, and by substitution of the T-G loops by T-T loops. Physical measurements have demonstrated that the substitution of propynyl dU or 5-amino dU for T in the T residues of the loops did not alter the structure of T30695, and these derivatives also formed an intramolecular G-quartet structure, which is an essential requirement for anti-HIV activity. Measured IC(50) and EC(50) values show that these substitutions did not induce an apparent decrease in the ability to inhibit HIV-1 integrase activity and in the inhibition of HIV-1 replication in cell culture. However, the substitution of T-T loops for T-G loops induced a substantial decrease in both thermal stability and anti-HIV activity. The data analysis of T30695 and the 21 derivatives shows a significant, functional correlation between thermal stability of the G-tetrad structure and the capacity to inhibit HIV-1 integrase activity and between thermal stability of the G-tetrad structure and the capacity to inhibit HIV-1 replication, as assessed with the virus strains HIV-1 RF, IIIB, and MN in cell culture. This relationship between thermostability and activity provides a basis for improving the efficacy of these compounds to inhibit HIV-1 integrase activity and HIV-1 replication in cell culture.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10652335     DOI: 10.1074/jbc.275.5.3421

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Investigation of formation, recognition, stabilization, and conversion of dimeric G-quadruplexes of HIV-1 integrase inhibitors by electrospray ionization mass spectrometry.

Authors:  Huihui Li; Gu Yuan; Daming Du
Journal:  J Am Soc Mass Spectrom       Date:  2008-02-05       Impact factor: 3.109

2.  Newly designed six-membered azasugar nucleotide-containing phosphorothioate oligonucleotides as potent human immunodeficiency virus type 1 inhibitors.

Authors:  Dong-Seong Lee; Kyeong-Eun Jung; Cheol-Hee Yoon; Hong Lim; Yong-Soo Bae
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

3.  Inhibition of human immunodeficiency virus type 1 activity in vitro by a new self-stabilized oligonucleotide with guanosine-thymidine quadruplex motifs.

Authors:  Jun-ichiro Suzuki; Naoko Miyano-Kurosaki; Tomoyuki Kuwasaki; Hiroaki Takeuchi; Gota Kawai; Hiroshi Takaku
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  T40214/PEI complex: a potent therapeutics for prostate cancer that targets STAT3 signaling.

Authors:  Priya Weerasinghe; Yifei Li; Yongli Guan; Ruiwen Zhang; David J Tweardy; Naijie Jing
Journal:  Prostate       Date:  2008-09-15       Impact factor: 4.104

5.  d(GGGT) 4 and r(GGGU) 4 are both HIV-1 inhibitors and interleukin-6 receptor aptamers.

Authors:  Eileen Magbanua; Tijana Zivkovic; Björn Hansen; Niklas Beschorner; Cindy Meyer; Inken Lorenzen; Joachim Grötzinger; Joachim Hauber; Andrew E Torda; Günter Mayer; Stefan Rose-John; Ulrich Hahn
Journal:  RNA Biol       Date:  2012-12-12       Impact factor: 4.652

6.  Enhanced anti-HIV-1 activity of G-quadruplexes comprising locked nucleic acids and intercalating nucleic acids.

Authors:  Erik B Pedersen; Jakob T Nielsen; Claus Nielsen; Vyacheslav V Filichev
Journal:  Nucleic Acids Res       Date:  2010-11-09       Impact factor: 16.971

7.  Short G-rich oligonucleotides as a potential therapeutic for Huntington's Disease.

Authors:  Michael Skogen; Jennifer Roth; Sarah Yerkes; Hetal Parekh-Olmedo; Eric Kmiec
Journal:  BMC Neurosci       Date:  2006-10-02       Impact factor: 3.288

Review 8.  Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human Viruses.

Authors:  Víctor M González; M Elena Martín; Gerónimo Fernández; Ana García-Sacristán
Journal:  Pharmaceuticals (Basel)       Date:  2016-12-16

9.  The Functional Role of Loops and Flanking Sequences of G-Quadruplex Aptamer to the Hemagglutinin of Influenza a Virus.

Authors:  Anastasia A Bizyaeva; Dmitry A Bunin; Valeria L Moiseenko; Alexandra S Gambaryan; Sonja Balk; Vadim N Tashlitsky; Alexander M Arutyunyan; Alexey M Kopylov; Elena G Zavyalova
Journal:  Int J Mol Sci       Date:  2021-02-27       Impact factor: 5.923

10.  Novel bimodular DNA aptamers with guanosine quadruplexes inhibit phylogenetically diverse HIV-1 reverse transcriptases.

Authors:  Daniel Michalowski; Rebecca Chitima-Matsiga; Daniel M Held; Donald H Burke
Journal:  Nucleic Acids Res       Date:  2008-11-07       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.